TiGenix NV (TIG) - Product Pipeline Analysis

TiGenix NV (TIG) - Product Pipeline Analysis

Aug 2012 GlobalData Market Guide53 Pages Price :
$ 750

TiGenix NV (TiGenix) is a publicly held biomedical cell therapy company. The company carries out the development of innovative local treatments for damaged and diseased tissues. It mainly focuses in the therapeutic area of Orthopedic, such as damaged cartilage and osteoarthritis joints. The company offers two marketed products, namely, ChondroCelect and ChondroMimetic. It also offers a strong product pipeline with clinical stage adult stem cell programs used for the treatment of inflammatory and autoimmune diseases. The company is developing a proprietary stem cell platform that can be used in cartilage, meniscus, bone, tendon and muscle tissue repair. Geographically, through its subsidiaries, the company has operations in Madrid, Spain; Cambridge, UK; and Sittard-Geleen, the Netherlands. TiGenix is headquartered in Leuven, Belgium.

The key business strategies of the company include enhanced focus on providing cell therapy treatments for damaged and diseased tissues. It also aims to maintain its existing partnerships and to enter new collaborative agreements to fuel its services. This is indicated by recent partnership and collaboration agreements signed with Finnish Red Cross Blood Service for ChondroCelect distribution in Finland and the acquisition of all outstanding shares in the Spanish cell therapy company, Cellerix. Currently, the company is carrying out a Phase IIa trial in rheumatoid arthritis. It also planning to start Phase III clinical trial in critical perianal fistulas in patients with Crohns disease and Phase I trial to identify the potential of intra-lymphatic administration of eASCs for the treatment of autoimmune disorders.

This report is a source for data, analysis and actionable intelligence on the TiGenix NV portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

  • Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
  • Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
  • Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
  • Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
  • Data on relevant clinical trials and product patent details, wherever applicable.
  • Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Develop competition strategies by identifying the status and likely launch of your competitors pipeline products through review of the clinical trials, stage and phase of development, etc.
  • Which are the next high-value products that your competitor would add in its portfolio? identify, understand and capitalize.
Table of Content

Table of Contents 2
List of Tables 4
List of Figures 5

TiGenix NV - Business Description 6

Key Facts 7
TiGenix NV - Major Products and Services 8
TiGenix NV Pipeline Products by Equipment Type 9
TiGenix NV Pipeline Products by Development Stage 11
TiGenix NV Pipeline Products by Therapy Area 13
TiGenix NV Pipeline Products by Trial Phase 15
TiGenix NV Pipeline Products by Milestone Summary 16
ChondroCelect 18
ChondroCelect Product Status 18
ChondroCelect Product Description 18
ChondroCelect Product Milestone 18
ChondroCelect Clinical Trial 19
ChondroCelect Product Patent Details 22
ChondroCelect 3D 26
ChondroCelect 3D Product Status 26
ChondroCelect 3D Product Description 26
ChondroCelect 3D Product Patent Details 26
ChondroMimetic 31
ChondroMimetic Product Status 31
ChondroMimetic Product Description 31
ChondroMimetic Product Milestone 31
ChondroMimetic Clinical Trial 32
ChondroMimetic Product Patent Details 33
ChondroMimetic - Bone Filler 39
ChondroMimetic - Bone Filler Product Status 39
ChondroMimetic - Bone Filler Product Description 39
MeniscoCelect 40
MeniscoCelect Product Status 40
MeniscoCelect Product Description 40
MeniscoCelect Product Patent Details 40
TiGenix NV - Key Competitors 45
TiGenix NV - Key Employees 46
TiGenix NV - Key Employee Biographies 47
TiGenix NV - Locations And Subsidiaries 48
Head Office 48
Other Locations & Subsidiaries 48
Recent Developments 49
TiGenix NV, Recent Developments 49
May 15, 2012: TiGenix Reports Q1 2012 Results 49
Apr 24, 2012: TiGenix Obtains Manufacturing License For European Production Facility 50
Mar 15, 2012: TiGenix Reports Sales Of 1.1m In 2011 50
Feb 16, 2012: TiGenix Announces Changes In Management Responsibilities 50
Nov 03, 2011: TiGenix Reports Q3 2011 Results 50
Aug 25, 2011: TiGenix Reports H1 2011 Results 50
Apr 29, 2011: TiGenix Announces Availability Of ChondroCelect In Belgium 51
Mar 17, 2011: TiGenix Reports Total Revenue Of 2.4m For 2010 52

Appendix 53
Methodology 53
About GlobalData 53
Contact Us 53
Disclaimer 53

List of Table


TiGenix NV, Key Facts 1
TiGenix NV Key Pipeline Products by Equipment Type 1
TiGenix NV Key Pipeline Products by Therapy Area 1
TiGenix NV Key Pipeline Products by Development Stage 1
TiGenix NV Key Pipeline Products by Trial Phase 1
TiGenix NV, Key Facts 7
TiGenix NV, Major Products and Services 8
TiGenix NV Number of Pipeline Products by Equipment Type 9
TiGenix NV Pipeline Products by Equipment Type 10
TiGenix NV Number of Pipeline Products by Development Stage 11
TiGenix NV Pipeline Products by Development Stage 12
TiGenix NV Number of Pipeline Products by Therapy Area 13
TiGenix NV Pipeline Products by Therapy Area 14
TiGenix NV Number of Pipeline Products by Trial Phase 15
TiGenix NV Pipeline Products by Trial Phase 15
TiGenix NV Number of Pipeline Products By Milestone Summary 16
TiGenix NV Pipeline Products by Milestone Summary 17
ChondroCelect - Product Status 18
ChondroCelect - Product Description 18
ChondroCelect - Product Milestone 18
ChondroCelect - Prospective Multicenter Randomized Controlled Trial of ChondroCelect (in an Autologous Chondrocyte Transplantation Procedure) vs Microfracture in the Repair of Symptomatic Defects of the Knee 19
ChondroCelect - Patent Details1 22
ChondroCelect - Patent Details2 22
ChondroCelect - Patent Details3 23
ChondroCelect - Patent Details4 23
ChondroCelect - Patent Details5 24
ChondroCelect - Patent Details6 24
ChondroCelect - Patent Details7 25
ChondroCelect - Patent Details8 25
ChondroCelect 3D - Product Status 26
ChondroCelect 3D - Product Description 26
ChondroCelect 3D - Patent Details1 26
ChondroCelect 3D - Patent Details2 27
ChondroCelect 3D - Patent Details3 27
ChondroCelect 3D - Patent Details4 28
ChondroCelect 3D - Patent Details5 28
ChondroCelect 3D - Patent Details6 29
ChondroCelect 3D - Patent Details7 29
ChondroCelect 3D - Patent Details8 30
ChondroMimetic - Product Status 31
ChondroMimetic - Product Description 31
ChondroMimetic - Product Milestone 31
ChondroMimetic - Pilot Clinical Trial of Chondromimetic 32
ChondroMimetic - Patent Details1 33
ChondroMimetic - Patent Details2 33
ChondroMimetic - Patent Details3 34
ChondroMimetic - Patent Details4 34
ChondroMimetic - Patent Details5 35
ChondroMimetic - Patent Details6 35
ChondroMimetic - Patent Details7 36
ChondroMimetic - Patent Details8 36
ChondroMimetic - Patent Details9 37
ChondroMimetic - Patent Details10 37
ChondroMimetic - Patent Details11 38
ChondroMimetic - Bone Filler - Product Status 39
ChondroMimetic - Bone Filler - Product Description 39
MeniscoCelect - Product Status 40
MeniscoCelect - Product Description 40
MeniscoCelect - Patent Details1 40
MeniscoCelect - Patent Details2 41
MeniscoCelect - Patent Details3 41
MeniscoCelect - Patent Details4 42
MeniscoCelect - Patent Details5 42
MeniscoCelect - Patent Details6 43
MeniscoCelect - Patent Details7 43
MeniscoCelect - Patent Details8 44
TiGenix NV, Key Employees 46
TiGenix NV, Key Employee Biographies 47
TiGenix NV, Subsidiaries 48

List of Chart


TiGenix NV Pipeline Products by Equipment Type 9
TiGenix NV Pipeline Products by Development Stage 11
TiGenix NV Pipeline Products by Therapy Area 13
TiGenix NV Pipeline Products by Trial Phase 15
TiGenix NV Pipeline Products by Milestone Summary 16

Ask for discount before buying this report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Your Requirement
  • Security Code *
* denotes fields which must be completed

Buy This Report


Select License Type :

$ 750
$ 1500

Do you wish to check sample of this report?

Have Query?


Research Assistance

For Enquiries, Call :

+1-800-998-4852US Toll Free

Email : sales@marketresearchhub.com

Back To Top